Transchem Limited reported a net profit of ₹342.11 lakh for the quarter ended June 30, 2026 (Q1FY26), marking a significant 244% year-on-year increase from ₹99.33 lakh in Q1FY25. The chemical manufacturer’s total income surged to ₹511.36 lakh, up from ₹163.58 lakh in the same period last year, driven by improved operational efficiency and strategic capital raising activities during the quarter.

The Board of Directors approved the unaudited financial results on August 10, 2026, in compliance with Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were subsequently published in Financial Express and Mumbai Lakshadeep under Regulation 47. The figures were reviewed by the Audit Committee and prepared in accordance with Indian Accounting Standards (Ind-AS) as prescribed under Section 133 of the Companies Act, 2013.

Financial Performance Highlights

Transchem’s profitability expanded substantially in the opening quarter of FY26. Pre-tax profit stood at ₹435.21 lakh, compared to ₹135.10 lakh in Q1FY25. Basic earnings per share (EPS) rose to ₹2.79 from ₹0.81 in the prior year period. However, diluted EPS was lower at ₹0.57 due to the inclusion of recently issued warrants, whereas it remained at ₹0.81 in Q1FY25 when no such dilutive instruments were outstanding.

Capital Raise and Dilution Impact

During the quarter, Transchem issued 6,15,00,000 warrants on a preferential basis to non-promoter entities at an issue price of ₹75 per warrant. The company received an upfront consideration of 25% of the issue price, amounting to ₹18.75 per warrant, aggregating to ₹115.31 lakh. Each warrant carries the option to subscribe to one fully paid-up equity share with a face value of ₹10. These warrants can be exercised within 18 months from the date of allotment as per SEBI (Issue of Capital and Disclosure Requirements) Regulations.

What the Numbers Show

The divergence between basic EPS (₹2.79) and diluted EPS (₹0.57) highlights the immediate accounting impact of the warrant issuance on per-share metrics. While the core operational profit grew more than threefold, the potential conversion of these warrants into equity shares will significantly reduce earnings per share if exercised. Investors should note that the ₹115.31 lakh upfront receipt represents only a fraction of the potential capital inflow if all warrants are converted at the full ₹75 strike price over the next 18 months.

Transchem Limited has filed an intimation with BSE Limited, dated July 31, 2026, under Regulation 30 read with Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication pertains to the dispatch of physical letters to those members whose email addresses are not registered with the company, its Registrar and Share Transfer Agent, Depository Participants, or the Depositories. These letters provide the web-link and exact navigation path to access the Notice of the 49th Annual General Meeting and the Annual Report for Financial Year 2025-26.

49th Annual General Meeting Details

The 49th Annual General Meeting of Transchem Limited is scheduled to be held on Saturday, September 05, 2026, at 11:00 a.m. (IST). The meeting will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM), in line with applicable regulatory provisions. The AGM notice and Annual Report for FY 2025-26 are being sent electronically to all shareholders whose email addresses are registered with the company, Depositories, or the Registrar and Transfer Agent (RTA).

For members whose email addresses are not on record, the company has provided the following access details:

The aforesaid documents are also available on the website of BSE Limited at www.bseindia.com .

SEBI Special Window for Physical Share Transfer Re-lodgement

Pursuant to a SEBI Circular dated January 30, 2026, a one-year special window has been opened from February 05, 2026, to February 04, 2027. This window allows investors to re-lodge physical share transfer deeds that were originally submitted before April 01, 2019, but were rejected or returned due to deficiencies. Eligible members are requested to rectify documentation issues and contact the company's RTA for assistance.

Shareholder Action Items

The company has requested shareholders to update their records as follows:

• Physical mode shareholders: Register or update email address, communication address, bank details, and nomination details by writing to the RTA at investor.helpdesk@in.mpms.mufg.com
• Dematerialized mode shareholders: Reach out to their respective Depository Participants at the earliest to update relevant details

The intimation was signed by Neeraja Karandikar, Company Secretary (ACS - 10130), on behalf of Transchem Limited. The company is registered at 111, Maker Chambers IV, 11th Floor, Nariman Point, Mumbai - 400021, with CIN: L66120MH1976PLC019327.